Biotechnology
The Biotechnology industry has a total of 592 stocks, with a combined market cap of $1.39 trillion and total revenue of $115.84 billion.
Market Cap
1.39T
Revenue
115.84B
Profits
-39.61B
PE Ratio
n/a
Profit Margin
-34.19%
Dividend Yield
0.04%
592 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 138.78B | 0.05% | 633,632 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 80.65B | -0.87% | 766,775 | 15.53B |
| 3 | ARGX | argenx SE | 66.11B | 1.13% | 322,514 | 5.32B |
| 4 | MRNA | Moderna, Inc. | 57.00B | -4.60% | 24,932,914 | 2.23B |
| 5 | RVMD | Revolution Medicines, Inc. | 47.40B | 2.65% | 3,355,005 | - |
| 6 | ONC | BeOne Medicines AG | 42.35B | -0.88% | 225,067 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 35.60B | 0.19% | 2,093,679 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.65B | -1.02% | 1,293,205 | 4.80B |
| 9 | BNTX | BioNTech SE | 27.98B | -1.03% | 1,551,124 | 3.03B |
| 10 | ROIV | Roivant Sciences Ltd. | 27.14B | 2.26% | 4,920,767 | 7.53M |
| 11 | INSM | Insmed Incorporated | 26.51B | -2.41% | 1,055,878 | 1.14B |
| 12 | INCY | Incyte Corporation | 25.89B | -0.30% | 700,345 | 5.82B |
| 13 | GMAB | Genmab A/S | 20.17B | 1.04% | 1,866,280 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 16.38B | -0.36% | 189,524 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 16.30B | 0.73% | 4,765,467 | 4.60B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 15.38B | -0.87% | 976,939 | 713.07M |
| 17 | EXEL | Exelixis, Inc. | 13.69B | -1.50% | 1,489,242 | 2.44B |
| 18 | CORT | Corcept Therapeutics Incorporated | 12.64B | -2.40% | 639,571 | 830.81M |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 12.64B | -0.49% | 1,245,964 | 3.41B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.56B | 0.89% | 221,851 | 1.28B |
| 21 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.51B | -0.59% | 857,456 | 669.50M |
| 22 | HALO | Halozyme Therapeutics, Inc. | 12.14B | -0.13% | 1,364,607 | 1.66B |
| 23 | SMMT | Summit Therapeutics Inc. | 11.43B | 0.70% | 4,836,607 | - |
| 24 | TECH | Bio-Techne Corporation | 11.36B | 0.12% | 1,683,886 | 1.22B |
| 25 | ABVX | ABIVAX Société Anonyme | 10.89B | -1.91% | 1,074,233 | 5.67M |
| 26 | CYTK | Cytokinetics, Incorporated | 10.83B | -1.64% | 1,089,856 | 67.67M |
| 27 | AXSM | Axsome Therapeutics, Inc. | 10.80B | -0.42% | 586,214 | 776.57M |
| 28 | KRYS | Krystal Biotech, Inc. | 10.58B | -0.64% | 181,370 | 440.48M |
| 29 | IONS | Ionis Pharmaceuticals, Inc. | 10.37B | -1.47% | 1,625,118 | 874.09M |
| 30 | PRAX | Praxis Precision Medicines, Inc. | 10.27B | -2.52% | 242,856 | 7.46M |
| 31 | APGE | Apogee Therapeutics, Inc. | 10.18B | 0.01% | 1,137,230 | - |
| 32 | KYMR | Kymera Therapeutics, Inc. | 10.00B | -4.24% | 595,314 | 105.00M |
| 33 | PTGX | Protagonist Therapeutics, Inc. | 9.67B | -1.32% | 381,477 | 281.99M |
| 34 | PCVX | Vaxcyte, Inc. | 9.10B | 0.11% | 611,452 | - |
| 35 | IMVT | Immunovant, Inc. | 9.05B | -0.16% | 667,014 | - |
| 36 | CRNX | Crinetics Pharmaceuticals, Inc. | 9.00B | 0.01% | 1,058,993 | 42.16M |
| 37 | IBRX | ImmunityBio, Inc. | 8.90B | 1.82% | 11,603,141 | 165.79M |
| 38 | SYRE | Spyre Therapeutics, Inc. | 8.25B | 0.01% | 1,165,262 | - |
| 39 | TGTX | TG Therapeutics, Inc. | 7.90B | 1.25% | 1,221,793 | 799.54M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.75B | 0.59% | 311,064 | 239.92M |
| 41 | CAI | Caris Life Sciences, Inc. | 7.45B | -1.64% | 10,904,093 | 989.61M |
| 42 | SRRK | Scholar Rock Holding Corporation | 7.22B | -1.30% | 596,909 | - |
| 43 | CGON | CG Oncology, Inc. | 7.00B | 0.75% | 328,892 | 6.23M |
| 44 | ERAS | Erasca, Inc. | 6.82B | 1.78% | 4,221,806 | - |
| 45 | MIRM | Mirum Pharmaceuticals, Inc. | 6.48B | 1.26% | 402,119 | 618.07M |
| 46 | COGT | Cogent Biosciences, Inc. | 6.44B | 1.01% | 1,636,556 | - |
| 47 | ORKA | Oruka Therapeutics, Inc. | 6.39B | -2.92% | 614,611 | - |
| 48 | TVTX | Travere Therapeutics, Inc. | 6.36B | 0.60% | 911,627 | 591.33M |
| 49 | BLTE | Belite Bio, Inc | 6.32B | 0.20% | 106,496 | - |
| 50 | DNTH | Dianthus Therapeutics, Inc. | 6.24B | 0.70% | 601,232 | 1.90M |
| 51 | XENE | Xenon Pharmaceuticals Inc. | 6.00B | -2.92% | 586,951 | 7.50M |
| 52 | PTCT | PTC Therapeutics, Inc. | 5.99B | -1.21% | 746,329 | 1.01B |
| 53 | DFTX | Definium Therapeutics, Inc. | 5.89B | 0.11% | 1,416,931 | - |
| 54 | CRSP | CRISPR Therapeutics AG | 5.74B | 0.24% | 1,186,880 | 13.39M |
| 55 | LGND | Ligand Pharmaceuticals Incorporated | 5.67B | -1.16% | 206,320 | 290.54M |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 5.12B | 0.51% | 879,334 | 1.14B |
| 57 | DYN | Dyne Therapeutics, Inc. | 4.87B | -1.02% | 1,018,664 | - |
| 58 | PBLS | Parabilis Medicines, Inc. | 4.85B | 0.08% | 445,429 | 148.00K |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 4.80B | -0.43% | 995,598 | - |
| 60 | CELC | Celcuity Inc. | 4.56B | -1.94% | 457,213 | - |
| 61 | ELVN | Enliven Therapeutics, Inc. | 4.43B | -0.60% | 523,765 | - |
| 62 | TNGX | Tango Therapeutics, Inc. | 4.26B | -0.75% | 1,704,052 | 53.81M |
| 63 | RLAY | Relay Therapeutics, Inc. | 4.26B | -0.21% | 2,394,416 | 10.35M |
| 64 | MANE | Veradermics, Incorporated | 4.25B | -0.96% | 260,329 | - |
| 65 | IDYA | IDEAYA Biosciences, Inc. | 4.03B | 0.46% | 534,276 | 234.13M |
| 66 | ABCL | AbCellera Biologics Inc. | 4.02B | 1.31% | 3,988,713 | 66.17M |
| 67 | LEGN | Legend Biotech Corporation | 3.97B | -0.87% | 1,015,544 | 1.27B |
| 68 | VKTX | Viking Therapeutics, Inc. | 3.95B | -1.51% | 2,205,811 | - |
| 69 | DNLI | Denali Therapeutics Inc. | 3.94B | 0.41% | 700,064 | 3.60M |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.90B | -0.55% | 786,473 | 117.00M |
| 71 | TLX | Telix Pharmaceuticals Limited | 3.81B | 2.20% | 73,769 | 890.79M |
| 72 | IOVA | Iovance Biotherapeutics, Inc. | 3.74B | 2.23% | 7,434,842 | 324.97M |
| 73 | GPCR | Structure Therapeutics Inc. | 3.51B | -0.26% | 318,893 | - |
| 74 | QURE | uniQure N.V. | 3.44B | -2.73% | 711,954 | 18.67M |
| 75 | IMNM | Immunome, Inc. | 3.28B | 0.42% | 920,721 | 4.02M |
| 76 | NAMS | NewAmsterdam Pharma Company N.V. | 3.20B | -2.23% | 626,804 | 7.12M |
| 77 | MBX | MBX Biosciences, Inc. | 3.20B | -0.55% | 263,495 | - |
| 78 | CLDX | Celldex Therapeutics, Inc. | 3.18B | -0.27% | 449,352 | 158.00K |
| 79 | IRON | Disc Medicine, Inc. | 3.17B | -0.15% | 324,129 | - |
| 80 | TARS | Tarsus Pharmaceuticals, Inc. | 3.16B | 1.80% | 876,367 | 606.33M |
| 81 | ARQT | Arcutis Biotherapeutics, Inc. | 3.13B | -1.07% | 2,204,608 | 463.98M |
| 82 | SLS | SELLAS Life Sciences Group, Inc. | 3.07B | 10.78% | 12,076,467 | - |
| 83 | BEAM | Beam Therapeutics Inc. | 3.05B | 0.96% | 1,268,873 | 156.04M |
| 84 | ZLAB | Zai Lab Limited | 3.01B | 3.03% | 597,324 | 449.61M |
| 85 | ALMS | Alumis Inc. | 3.00B | -1.74% | 478,312 | 7.40M |
| 86 | NRIX | Nurix Therapeutics, Inc. | 2.79B | 0.62% | 1,214,116 | 36.77M |
| 87 | ATAI | AtaiBeckley Inc. | 2.73B | -0.54% | 3,034,219 | 4.47M |
| 88 | VRDN | Viridian Therapeutics, Inc. | 2.71B | -1.57% | 839,734 | 71.13M |
| 89 | PHVS | Pharvaris N.V. | 2.60B | - | 765,047 | - |
| 90 | RARE | Ultragenyx Pharmaceutical Inc. | 2.58B | -0.68% | 1,142,509 | 717.00M |
| 91 | PGEN | Precigen, Inc. | 2.57B | -3.10% | 4,054,647 | 85.72M |
| 92 | TRVI | Trevi Therapeutics, Inc. | 2.56B | 0.22% | 1,231,223 | - |
| 93 | NKTR | Nektar Therapeutics | 2.55B | 1.06% | 340,346 | 54.59M |
| 94 | VERA | Vera Therapeutics, Inc. | 2.49B | -6.03% | 2,706,275 | - |
| 95 | NUVB | Nuvation Bio Inc. | 2.45B | 0.43% | 3,530,095 | 169.90M |
| 96 | KOD | Kodiak Sciences Inc. | 2.45B | -0.53% | 369,554 | - |
| 97 | RAPP | Rapport Therapeutics, Inc. | 2.44B | -3.18% | 382,832 | 20.00M |
| 98 | BHVN | Biohaven Ltd. | 2.43B | -4.90% | 5,426,637 | - |
| 99 | KLRA | Kailera Therapeutics, Inc. | 2.40B | 0.49% | 439,506 | - |
| 100 | OCUL | Ocular Therapeutix, Inc. | 2.38B | 0.46% | 1,427,216 | 52.06M |
| 101 | HRMY | Harmony Biosciences Holdings, Inc. | 2.32B | 0.53% | 497,428 | 959.90M |
| 102 | COAG | Hemab Therapeutics Holdings, Inc. | 2.31B | 0.61% | 354,963 | - |
| 103 | MLYS | Mineralys Therapeutics, Inc. | 2.30B | 0.46% | 420,746 | - |
| 104 | SRPT | Sarepta Therapeutics, Inc. | 2.28B | 10.95% | 7,918,665 | 1.97B |
| 105 | NBTX | Nanobiotix S.A. | 2.28B | 1.48% | 347,804 | 38.27M |
| 106 | MESO | Mesoblast Limited | 2.25B | 7.96% | 541,630 | 120.25M |
| 107 | URGN | UroGen Pharma Ltd. | 2.22B | -0.96% | 559,747 | 188.73M |
| 108 | AUPH | Aurinia Pharmaceuticals Inc. | 2.19B | -0.39% | 838,333 | 311.51M |
| 109 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.17B | -5.96% | 3,170,535 | 208.78M |
| 110 | PVLA | Palvella Therapeutics, Inc. | 2.17B | -2.59% | 232,748 | - |
| 111 | XNCR | Xencor, Inc. | 2.15B | 1.55% | 1,552,933 | 104.97M |
| 112 | ZBIO | Zenas BioPharma, Inc. | 2.13B | -1.27% | 658,972 | 1.00M |
| 113 | ADMA | ADMA Biologics, Inc. | 2.12B | -1.56% | 1,496,256 | 512.28M |
| 114 | VCEL | Vericel Corporation | 2.11B | -2.97% | 533,420 | 306.30M |
| 115 | STOK | Stoke Therapeutics, Inc. | 2.10B | -1.51% | 939,328 | 27.59M |
| 116 | ZYME | Zymeworks Inc. | 2.06B | -1.01% | 625,125 | 37.13M |
| 117 | AGIO | Agios Pharmaceuticals, Inc. | 2.05B | 0.85% | 883,837 | 98.34M |
| 118 | GENB | Generate Biomedicines, Inc. | 2.02B | -2.29% | 2,858,496 | 26.48M |
| 119 | GHRS | GH Research PLC | 1.97B | -1.24% | 73,500 | - |
| 120 | KARD | Kardigan, Inc. | 1.94B | -1.79% | 546,649 | - |
| 121 | TSHA | Taysha Gene Therapies, Inc. | 1.94B | -1.00% | 2,187,198 | 5.49M |
| 122 | FBRX | Forte Biosciences, Inc. | 1.94B | - | - | - |
| 123 | LKFT | Lakefront Biotherapeutics NV | 1.92B | 0.96% | 156,380 | 1.13B |
| 124 | VIR | Vir Biotechnology, Inc. | 1.91B | 2.08% | 1,737,300 | 303.23M |
| 125 | IMCR | Immunocore Holdings plc | 1.89B | -1.00% | 270,098 | 430.78M |
| 126 | DMRA | Damora Therapeutics, Inc. | 1.89B | 0.69% | 171,252 | - |
| 127 | SEPN | Septerna, Inc. | 1.89B | 0.55% | 266,542 | 98.88M |
| 128 | RXRX | Recursion Pharmaceuticals, Inc. | 1.84B | -1.43% | 10,050,083 | 54.86M |
| 129 | NTLA | Intellia Therapeutics, Inc. | 1.84B | -0.61% | 2,443,903 | 59.51M |
| 130 | INBX | Inhibrx Biosciences, Inc. | 1.82B | -1.12% | 310,836 | 1.30M |
| 131 | SNDX | Syndax Pharmaceuticals, Inc. | 1.80B | 0.35% | 652,350 | 252.25M |
| 132 | FTRE | Fortrea Holdings Inc. | 1.79B | 1.78% | 1,323,440 | 2.68B |
| 133 | BRVE | Braveheart Bio, Inc. | 1.79B | 0.36% | 127,847 | - |
| 134 | AAPG | Ascentage Pharma Group International | 1.73B | 10.83% | 15,520 | 94.61M |
| 135 | ANAB | AnaptysBio, Inc. | 1.70B | -1.22% | 533,687 | 232.39M |
| 136 | BCAX | Bicara Therapeutics Inc. | 1.64B | 0.40% | 445,006 | - |
| 137 | AVLN | Avalyn Pharma Inc. | 1.62B | -1.43% | 129,003 | - |
| 138 | ABSI | Absci Corporation | 1.62B | 2.17% | 3,210,172 | 1.56M |
| 139 | TRAX | First Tracks Biotherapeutics, Inc. | 1.60B | 1.24% | 352,564 | - |
| 140 | APMD | Apnimed, Inc. | 1.59B | -2.91% | 421,715 | 120.15M |
| 141 | MAZE | Maze Therapeutics, Inc. | 1.59B | -3.31% | 692,410 | 20.00M |
| 142 | LTGO | Latigo Biotherapeutics, Inc. | 1.58B | 3.61% | 235,526 | - |
| 143 | TYRA | Tyra Biosciences, Inc. | 1.56B | -0.34% | 253,973 | - |
| 144 | LBRX | LB Pharmaceuticals Inc | 1.54B | -0.57% | 256,064 | - |
| 145 | AVBP | ArriVent BioPharma, Inc. | 1.53B | -0.45% | 299,970 | - |
| 146 | INVA | Innoviva, Inc. | 1.51B | -1.32% | 407,824 | 440.00M |
| 147 | SLBT | SL Science Holding Limited | 1.51B | 1.54% | 37,044 | 3.27M |
| 148 | NVAX | Novavax, Inc. | 1.49B | -1.74% | 3,422,889 | 413.80M |
| 149 | REPL | Replimune Group, Inc. | 1.47B | -1.76% | 1,670,526 | - |
| 150 | AKTS | Aktis Oncology, Inc. | 1.46B | -1.24% | 210,624 | 10.06M |
| 151 | CGEM | Cullinan Therapeutics, Inc. | 1.45B | -1.09% | 471,907 | - |
| 152 | ANRO | Alto Neuroscience, Inc. | 1.42B | -0.63% | 320,031 | - |
| 153 | ORIC | ORIC Pharmaceuticals, Inc. | 1.42B | -1.22% | 1,060,958 | - |
| 154 | SPTX | Seaport Therapeutics, Inc. | 1.41B | -5.71% | 128,656 | - |
| 155 | SVRA | Savara Inc. | 1.40B | -2.14% | 1,595,280 | - |
| 156 | OMER | Omeros Corporation | 1.39B | 5.65% | 1,756,247 | 38.42M |
| 157 | VOR | Vor Biopharma Inc. | 1.39B | -0.59% | 622,121 | - |
| 158 | DRTS | Alpha Tau Medical Ltd. | 1.37B | -1.00% | 447,171 | - |
| 159 | MGTX | MeiraGTx Holdings plc | 1.36B | -2.88% | 955,114 | 397.50M |
| 160 | JBIO | Jade Biosciences, Inc. | 1.35B | -0.19% | 342,543 | - |
| 161 | MLTX | MoonLake Immunotherapeutics | 1.32B | -0.58% | 1,099,382 | - |
| 162 | MNKD | MannKind Corporation | 1.31B | -0.73% | 1,748,670 | 393.63M |
| 163 | IMTX | Immatics N.V. | 1.28B | -0.74% | 742,184 | 47.65M |
| 164 | ODTX | Odyssey Therapeutics, Inc. | 1.24B | 1.37% | 141,356 | 99.00K |
| 165 | CRVS | Corvus Pharmaceuticals, Inc. | 1.24B | -0.07% | 508,072 | - |
| 166 | SANA | Sana Biotechnology, Inc. | 1.22B | -1.68% | 1,511,967 | - |
| 167 | GLUE | Monte Rosa Therapeutics, Inc. | 1.22B | -0.42% | 1,080,949 | 28.73M |
| 168 | KURA | Kura Oncology, Inc. | 1.17B | 0.92% | 2,366,273 | 77.23M |
| 169 | IVA | Inventiva S.A. | 1.17B | 1.66% | 865,632 | 7.94M |
| 170 | JANX | Janux Therapeutics, Inc. | 1.15B | -0.58% | 577,311 | 24.00M |
| 171 | SLDB | Solid Biosciences Inc. | 1.09B | 4.22% | 988,927 | - |
| 172 | AVTX | Avalo Therapeutics, Inc. | 1.08B | -2.43% | 420,139 | 59.00K |
| 173 | CADL | Candel Therapeutics, Inc. | 1.05B | 3.54% | 1,180,181 | - |
| 174 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | 0.43% | 1,616,417 | 41.47M |
| 175 | IMMX | Immix Biopharma, Inc. | 1.02B | 1.71% | 1,510,925 | - |
| 176 | ABUS | Arbutus Biopharma Corporation | 1.02B | -0.39% | 3,575,868 | 181.72M |
| 177 | WVE | Wave Life Sciences, Inc. | 1.02B | -1.34% | 2,949,828 | 65.37M |
| 178 | ANNX | Annexon, Inc. | 995.29M | 5.21% | 3,022,694 | - |
| 179 | GERN | Geron Corporation | 982.98M | - | 7,883,087 | 204.56M |
| 180 | HELP | Cybin Inc. | 967.32M | -2.86% | 797,530 | - |
| 181 | DSGN | Design Therapeutics, Inc. | 954.37M | -2.18% | 389,182 | - |
| 182 | ARDX | Ardelyx, Inc. | 951.90M | -0.26% | 2,285,846 | 450.89M |
| 183 | OLMA | Olema Pharmaceuticals, Inc. | 944.10M | -0.55% | 383,336 | - |
| 184 | ATTO | Attovia Therapeutics, Inc. | 923.40M | 9.77% | 137,305 | 1.35M |
| 185 | ANL | Adlai Nortye Ltd. | 922.18M | -4.91% | 137,004 | 18.06M |
| 186 | ACRS | Aclaris Therapeutics, Inc. | 906.75M | -0.48% | 1,408,994 | 8.22M |
| 187 | SGP | SpyGlass Pharma, Inc. | 900.75M | 1.09% | 66,047 | - |
| 188 | TBPH | Theravance Biopharma, Inc. | 884.70M | 0.06% | 487,328 | 104.31M |
| 189 | RIGL | Rigel Pharmaceuticals, Inc. | 875.34M | 0.82% | 210,026 | 276.79M |
| 190 | FTH | Faeth Therapeutics, Inc. | 871.86M | 2.34% | 198,583 | - |
| 191 | CLYM | Climb Bio, Inc. | 864.99M | -6.34% | 1,552,440 | - |
| 192 | DBVT | DBV Technologies S.A. | 854.24M | -0.76% | 130,918 | 5.04M |
| 193 | ACHV | Achieve Life Sciences, Inc. | 841.74M | -1.09% | 987,653 | - |
| 194 | PHAR | Pharming Group N.V. | 832.78M | -1.42% | 6,428 | 366.48M |
| 195 | FDMT | 4D Molecular Therapeutics, Inc. | 823.69M | -4.18% | 717,546 | 92.01M |
| 196 | NVCT | Nuvectis Pharma, Inc. | 820.73M | 0.76% | 319,793 | - |
| 197 | SLN | Silence Therapeutics plc | 809.82M | -0.59% | 283,574 | 615.00K |
| 198 | AURA | Aura Biosciences, Inc. | 798.53M | -0.39% | 440,768 | - |
| 199 | STTK | Shattuck Labs, Inc. | 767.78M | -3.16% | 542,881 | 1.00M |
| 200 | OCS | Oculis Holding AG | 767.33M | -4.16% | 111,280 | 1.45M |
| 201 | MNPR | Monopar Therapeutics Inc. | 764.78M | 0.19% | 142,825 | - |
| 202 | DRUG | Bright Minds Biosciences Inc. | 760.37M | -2.73% | 61,692 | - |
| 203 | CBIO | Crescent Biopharma, Inc. | 760.15M | -1.44% | 76,669 | 11.88M |
| 204 | NGNE | Neurogene Inc. | 757.63M | -1.43% | 132,067 | 925.00K |
| 205 | CTMX | CytomX Therapeutics, Inc. | 745.22M | 3.01% | 2,391,344 | 18.30M |
| 206 | OBX | Obsidian Therapeutics, Inc. | 738.28M | -7.39% | 65,062 | - |
| 207 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 736.00M | -0.86% | 385,265 | - |
| 208 | ALLO | Allogene Therapeutics, Inc. | 722.08M | 2.45% | 4,965,318 | 4.64M |
| 209 | TECX | Tectonic Therapeutic, Inc. | 717.46M | 2.03% | 278,104 | - |
| 210 | PHAT | Phathom Pharmaceuticals, Inc. | 710.11M | 1.94% | 1,047,090 | 239.66M |
| 211 | ASMB | Assembly Biosciences, Inc. | 708.55M | -1.75% | 192,092 | 74.85M |
| 212 | GYRE | Gyre Therapeutics, Inc. | 708.31M | 0.45% | 25,343 | 109.82M |
| 213 | ZVRA | Zevra Therapeutics, Inc. | 703.70M | 0.94% | 620,351 | 136.07M |
| 214 | MPLT | MapLight Therapeutics, Inc. | 696.92M | -2.49% | 741,533 | - |
| 215 | AGMB | AgomAb Therapeutics NV | 681.59M | -3.08% | 154,165 | - |
| 216 | OABI | OmniAb, Inc. | 670.25M | -4.16% | 1,281,964 | 38.46M |
| 217 | VSTM | Verastem, Inc. | 668.36M | -0.14% | 1,300,202 | 87.53M |
| 218 | SGMT | Sagimet Biosciences Inc. | 668.21M | -1.01% | 581,691 | - |
| 219 | MDXG | MiMedx Group, Inc. | 657.38M | 2.04% | 1,050,356 | 355.17M |
| 220 | PRLD | Prelude Therapeutics Incorporated | 652.99M | -3.35% | 364,168 | 22.42M |
| 221 | CTNM | Contineum Therapeutics, Inc. | 648.96M | 1.35% | 432,418 | - |
| 222 | CRMD | CorMedix Inc. | 647.72M | -0.95% | 703,880 | 462.25M |
| 223 | PRME | Prime Medicine, Inc. | 647.57M | 1.68% | 1,832,772 | 4.07M |
| 224 | ALT | Altimmune, Inc. | 630.24M | 2.86% | 2,080,968 | 31.00K |
| 225 | AUTL | Autolus Therapeutics plc | 628.14M | 1.29% | 1,229,634 | 117.39M |
| 226 | EIKN | Eikon Therapeutics, Inc. | 623.98M | -3.84% | 261,657 | - |
| 227 | VALN | Valneva SE | 621.92M | -2.02% | 21,498 | 163.30M |
| 228 | RGNX | REGENXBIO Inc. | 618.54M | -0.11% | 874,895 | 174.48M |
| 229 | BLSM | BlossomHill Therapeutics, Inc. | 606.74M | 7.26% | 102,308 | - |
| 230 | ARVN | Arvinas, Inc. | 604.17M | -0.86% | 527,001 | 316.70M |
| 231 | SPRY | ARS Pharmaceuticals, Inc. | 599.67M | - | 1,190,304 | 116.93M |
| 232 | CAPR | Capricor Therapeutics, Inc. | 584.88M | 7.48% | 12,034,148 | 11.13M |
| 233 | ARTV | Artiva Biotherapeutics, Inc. | 583.75M | 1.44% | 218,266 | 251.00K |
| 234 | CABA | Cabaletta Bio, Inc. | 573.06M | 4.00% | 3,800,445 | - |
| 235 | OVID | Ovid Therapeutics Inc. | 572.22M | 1.74% | 1,614,572 | 1.58M |
| 236 | ZURA | Zura Bio Limited | 560.60M | -2.34% | 873,010 | - |
| 237 | PROK | ProKidney Corp. | 550.23M | 4.60% | 1,103,540 | 818.00K |
| 238 | SCTX | Scribe Therapeutics Inc. | 544.05M | -9.02% | 194,645 | 36.28M |
| 239 | KYTX | Kyverna Therapeutics, Inc. | 534.33M | 0.35% | 432,407 | - |
| 240 | ENTX | Entera Bio Ltd. | 533.28M | -3.45% | 240,572 | 42.00K |
| 241 | RZLT | Rezolute, Inc. | 520.24M | -1.19% | 642,819 | - |
| 242 | EDIT | Editas Medicine, Inc. | 506.81M | 3.77% | 2,664,978 | 47.01M |
| 243 | CCCC | C4 Therapeutics, Inc. | 504.40M | -3.30% | 1,988,436 | 35.04M |
| 244 | EVMN | Evommune, Inc. | 489.22M | -4.46% | 252,447 | 10.00M |
| 245 | DNA | Ginkgo Bioworks Holdings, Inc. | 488.89M | 0.41% | 757,143 | 132.42M |
| 246 | EPRX | Eupraxia Pharmaceuticals Inc. | 487.92M | -0.94% | 208,527 | - |
| 247 | RLMD | Relmada Therapeutics, Inc. | 482.15M | -0.66% | 496,482 | - |
| 248 | QTTB | Q32 Bio Inc. | 480.78M | -0.19% | 148,268 | 53.74M |
| 249 | PBYI | Puma Biotechnology, Inc. | 476.97M | 0.87% | 202,693 | 231.24M |
| 250 | VOGX | Vogenx, Inc. | 468.05M | 2.28% | 135,729 | - |
| 251 | PRTA | Prothena Corporation plc | 466.65M | -1.73% | 338,880 | 54.53M |
| 252 | OCGN | Ocugen, Inc. | 464.58M | -2.84% | 2,897,610 | 4.58M |
| 253 | ARCT | Arcturus Therapeutics Holdings Inc. | 459.60M | 2.15% | 1,131,844 | 29.37M |
| 254 | CMPX | Compass Therapeutics, Inc. | 453.82M | 3.70% | 1,515,731 | 850.00K |
| 255 | IKT | Inhibikase Therapeutics, Inc. | 449.72M | -0.80% | 201,998 | 1.00 |
| 256 | AVIR | Atea Pharmaceuticals, Inc. | 437.12M | -1.09% | 102,868 | - |
| 257 | BNTC | Benitec Biopharma Inc. | 436.64M | -1.32% | 103,136 | - |
| 258 | LRMR | Larimar Therapeutics, Inc. | 422.75M | -2.88% | 672,764 | - |
| 259 | XFOR | X4 Pharmaceuticals, Inc. | 419.39M | 1.44% | 597,226 | 15.85M |
| 260 | GALT | Galectin Therapeutics Inc. | 417.52M | -0.24% | 345,232 | - |
| 261 | FENC | Fennec Pharmaceuticals Inc. | 412.74M | -3.29% | 296,418 | 59.22M |
| 262 | LXEO | Lexeo Therapeutics, Inc. | 409.39M | -0.40% | 1,105,628 | - |
| 263 | VTVT | vTv Therapeutics Inc. | 407.53M | -2.29% | 58,434 | 36.84M |
| 264 | IPSC | Century Therapeutics, Inc. | 403.80M | 4.21% | 525,701 | 109.16M |
| 265 | ENTA | Enanta Pharmaceuticals, Inc. | 401.93M | -2.47% | 228,921 | 65.26M |
| 266 | EYPT | EyePoint, Inc. | 399.16M | -7.21% | 5,992,930 | 2.79M |
| 267 | RCKT | Rocket Pharmaceuticals, Inc. | 397.38M | -1.09% | 1,258,409 | - |
| 268 | UPB | Upstream Bio, Inc. | 371.90M | -4.77% | 335,050 | 3.16M |
| 269 | FHTX | Foghorn Therapeutics Inc. | 369.38M | -7.03% | 432,627 | 36.74M |
| 270 | PALI | Palisade Bio, Inc. | 367.71M | -0.94% | 899,068 | 500.00K |
| 271 | ZNTL | Zentalis Pharmaceuticals, Inc. | 367.33M | -0.26% | 430,091 | 26.87M |
| 272 | DMAC | DiaMedica Therapeutics Inc. | 364.00M | 0.75% | 113,811 | - |
| 273 | LYEL | Lyell Immunopharma, Inc. | 358.02M | -1.28% | 88,376 | 27.00K |
| 274 | SABS | SAB Biotherapeutics, Inc. | 357.58M | 1.29% | 282,215 | 114.70K |
| 275 | STRO | Sutro Biopharma, Inc. | 353.34M | -0.56% | 92,124 | 45.70M |
| 276 | AGEN | Agenus Inc. | 351.61M | -5.33% | 782,653 | 132.69M |
| 277 | ABEO | Abeona Therapeutics Inc. | 345.39M | 0.50% | 537,221 | 25.52M |
| 278 | IMRX | Immuneering Corporation | 337.07M | 1.17% | 787,722 | - |
| 279 | IFRX | InflaRx N.V. | 334.53M | -6.20% | 1,081,797 | -11.54K |
| 280 | CUVL | Clinuvel Pharmaceuticals Limited | 332.99M | -11.44% | 30,740 | 65.05M |
| 281 | VNDA | Vanda Pharmaceuticals Inc. | 328.92M | 1.68% | 545,471 | 215.72M |
| 282 | PRQR | ProQR Therapeutics N.V. | 327.40M | -1.28% | 1,286,741 | 21.05M |
| 283 | IRD | Opus Genetics, Inc. | 320.30M | 1.32% | 501,884 | 9.86M |
| 284 | VCRE | Vicore Pharma Holding AB (publ) | 318.32M | -1.85% | 4,026 | 412.09K |
| 285 | OBIO | Orchestra BioMed Holdings, Inc. | 307.14M | -2.85% | 220,518 | 31.98M |
| 286 | FATE | Fate Therapeutics, Inc. | 304.34M | -1.17% | 1,574,376 | 6.49M |
| 287 | BCYC | Bicycle Therapeutics plc | 303.07M | -0.57% | 104,902 | 61.21M |
| 288 | RNAC | Cartesian Therapeutics, Inc. | 301.65M | -2.16% | 61,709 | 1.48M |
| 289 | TTRX | Turn Therapeutics Inc. | 301.16M | 4.98% | 47,587 | - |
| 290 | FULC | Fulcrum Therapeutics, Inc. | 293.74M | -0.26% | 785,024 | 80.00M |
| 291 | LCTX | Lineage Cell Therapeutics, Inc. | 293.37M | 3.57% | 917,794 | 13.08M |
| 292 | AVXL | Anavex Life Sciences Corp. | 290.06M | -3.40% | 652,700 | - |
| 293 | ALXO | ALX Oncology Holdings Inc. | 283.47M | 3.54% | 628,120 | - |
| 294 | SRZN | Surrozen, Inc. | 282.20M | 1.27% | 340,746 | 11.51M |
| 295 | NMRA | Neumora Therapeutics, Inc. | 278.09M | -5.13% | 533,849 | - |
| 296 | WHWK | Whitehawk Therapeutics, Inc. | 277.63M | 0.62% | 312,464 | 7.15M |
| 297 | PYXS | Pyxis Oncology, Inc. | 276.91M | -0.60% | 396,663 | 11.04M |
| 298 | GLSI | Greenwich LifeSciences, Inc. | 274.92M | 2.74% | 64,156 | - |
| 299 | SION | Sionna Therapeutics, Inc. | 273.99M | -1.78% | 659,433 | - |
| 300 | YDES | YD Bio Limited | 272.14M | -10.83% | 26,995 | 510.36K |
| 301 | ELDN | Eledon Pharmaceuticals, Inc. | 270.05M | -0.90% | 970,576 | - |
| 302 | ACIU | AC Immune SA | 269.45M | -4.91% | 169,427 | 21.67M |
| 303 | ALEC | Alector, Inc. | 266.86M | -2.85% | 706,856 | 13.86M |
| 304 | IVVD | Invivyd, Inc. | 265.31M | -0.18% | 1,718,784 | 58.37M |
| 305 | TRDA | Entrada Therapeutics, Inc. | 262.13M | 3.86% | 248,591 | 4.69M |
| 306 | ADAG | Adagene Inc. | 261.86M | 1.30% | 296,245 | 9.29M |
| 307 | CGEN | Compugen Ltd. | 261.44M | -2.82% | 301,259 | 74.00M |
| 308 | MGNX | MacroGenics, Inc. | 259.90M | 0.99% | 319,923 | 175.14M |
| 309 | CAMP | Camp4 Therapeutics Corporation | 259.80M | -1.43% | 684,833 | 4.22M |
| 310 | CLLS | Cellectis S.A. | 256.64M | 3.95% | 10,170 | 63.82M |
| 311 | NAGE | Niagen Bioscience, Inc. | 254.53M | -2.73% | 466,361 | 129.08M |
| 312 | NGEN | NervGen Pharma Corp. | 251.07M | 5.66% | 969,409 | - |
| 313 | NERV | Minerva Neurosciences, Inc. | 244.94M | -5.52% | 89,815 | - |
| 314 | RNA | Atrium Therapeutics, Inc. | 239.14M | 0.94% | 120,386 | 35.84M |
| 315 | SLGL | Sol-Gel Technologies Ltd. | 237.59M | -8.64% | 58,489 | 1.80M |
| 316 | TARA | Protara Therapeutics, Inc. | 235.79M | 2.05% | 256,730 | - |
| 317 | TNXP | Tonix Pharmaceuticals Holding Corp. | 232.57M | -0.59% | 541,386 | 29.10M |
| 318 | DTIL | Precision BioSciences, Inc. | 231.85M | -1.06% | 274,743 | 45.06M |
| 319 | CHRS | Coherus Oncology, Inc. | 225.57M | 0.69% | 788,164 | 50.94M |
| 320 | KROS | Keros Therapeutics, Inc. | 223.06M | 1.17% | 127,547 | 15.01M |
| 321 | IMUX | Immunic, Inc. | 222.40M | -1.15% | 162,874 | - |
| 322 | NBP | NovaBridge Biosciences | 219.24M | 1.07% | 249,152 | - |
| 323 | ABOS | Acumen Pharmaceuticals, Inc. | 219.12M | 1.34% | 270,760 | - |
| 324 | ANTX | AN2 Therapeutics, Inc. | 216.61M | 3.80% | 204,039 | - |
| 325 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 215.27M | -1.50% | 325,826 | - |
| 326 | VYGR | Voyager Therapeutics, Inc. | 213.20M | - | 262,597 | 34.46M |
| 327 | PEPG | PepGen Inc. | 212.63M | -4.66% | 440,207 | - |
| 328 | ORMP | Oramed Pharmaceuticals Inc. | 212.15M | -4.49% | 276,319 | 2.00M |
| 329 | ACOG | Alpha Cognition Inc. | 212.01M | 3.45% | 155,570 | 15.26M |
| 330 | PLX | Protalix BioTherapeutics, Inc. | 210.29M | 5.24% | 1,292,829 | 80.62M |
| 331 | IPHA | Innate Pharma S.A. | 205.48M | 3.24% | 6,047 | 10.57M |
| 332 | CUE | Cue Biopharma, Inc. | 204.57M | -2.39% | 225,399 | 37.66M |
| 333 | ARMP | Armata Pharmaceuticals, Inc. | 201.90M | -0.37% | 270,442 | 5.54M |
| 334 | MSLE | Satellos Bioscience Inc. | 199.85M | 2.67% | 8,648 | - |
| 335 | NKTX | Nkarta, Inc. | 196.97M | 4.56% | 538,664 | - |
| 336 | KRRO | Korro Bio, Inc. | 195.26M | -3.07% | 48,542 | 2.38M |
| 337 | KZIA | Kazia Therapeutics Limited | 193.11M | 15.75% | 944,890 | 1.27M |
| 338 | HUMA | Humacyte, Inc. | 192.43M | 1.63% | 2,961,813 | 2.12M |
| 339 | CNXU | Conexeu Sciences Inc. | 188.38M | 0.93% | 227,722 | - |
| 340 | CNTN | Canton Strategic Holdings, Inc. | 187.25M | 5.38% | 381,792 | 1.50M |
| 341 | SPRB | Spruce Biosciences, Inc. | 181.93M | 2.96% | 80,297 | 697.00K |
| 342 | CDXS | Codexis, Inc. | 181.78M | 0.61% | 591,818 | 77.68M |
| 343 | MOLN | Molecular Partners AG | 178.74M | 4.55% | 4,618 | 856.30K |
| 344 | CRBU | Caribou Biosciences, Inc. | 177.96M | 0.61% | 900,796 | 10.04M |
| 345 | MENS | Jyong Biotech Ltd. | 172.96M | 4.02% | 13,834 | - |
| 346 | MDWD | MediWound Ltd. | 170.93M | 4.25% | 196,214 | 11.86M |
| 347 | MIST | Milestone Pharmaceuticals Inc. | 167.68M | 0.85% | 1,539,015 | 2.34M |
| 348 | NRXP | NRx Pharmaceuticals, Inc. | 156.61M | 4.62% | 581,958 | 3.39M |
| 349 | OTLK | Outlook Therapeutics, Inc. | 156.07M | 2.86% | 6,615,840 | -1.16M |
| 350 | TNYA | Tenaya Therapeutics, Inc. | 155.88M | -0.14% | 1,243,463 | 1.34M |
| 351 | EQ | Equillium, Inc. | 155.35M | 3.81% | 364,013 | 4.39M |
| 352 | OKUR | OnKure Therapeutics, Inc. | 155.10M | 0.79% | 97,729 | - |
| 353 | INDP | Indaptus Therapeutics, Inc. | 154.56M | 1.75% | 404,501 | - |
| 354 | UNCY | Unicycive Therapeutics, Inc. | 153.20M | 1.29% | 366,031 | - |
| 355 | LENZ | LENZ Therapeutics, Inc. | 151.13M | 0.63% | 439,221 | 21.48M |
| 356 | AARD | Aardvark Therapeutics, Inc. | 144.88M | -2.79% | 74,109 | - |
| 357 | CNTB | Connect Biopharma Holdings Limited | 143.58M | -2.15% | 537,073 | 2.95M |
| 358 | TLSA | Tiziana Life Sciences Ltd | 139.65M | -0.92% | 272,311 | - |
| 359 | HURA | TuHURA Biosciences, Inc. | 135.74M | - | 96,739 | - |
| 360 | BDTX | Black Diamond Therapeutics, Inc. | 130.42M | - | 428,976 | 70.00M |
| 361 | INO | Inovio Pharmaceuticals, Inc. | 130.28M | -3.08% | 2,244,563 | 65.34K |
| 362 | GNLX | Genelux Corporation | 129.06M | 5.49% | 592,412 | 8.00K |
| 363 | ENGN | enGene Therapeutics Inc. | 127.95M | -2.05% | 251,592 | - |
| 364 | CBUS | Cibus, Inc. | 127.64M | -0.60% | 83,581 | 4.35M |
| 365 | VANI | Vivani Medical, Inc. | 126.28M | -1.06% | 86,718 | - |
| 366 | PMN | ProMIS Neurosciences, Inc. | 125.46M | -3.25% | 17,405 | - |
| 367 | TENX | Tenax Therapeutics, Inc. | 125.45M | 3.30% | 2,431,271 | - |
| 368 | ANIX | Anixa Biosciences, Inc. | 122.48M | -0.14% | 337,330 | - |
| 369 | BMEA | Biomea Fusion, Inc. | 121.77M | -1.75% | 1,803,159 | - |
| 370 | RANI | Rani Therapeutics Holdings, Inc. | 119.07M | 1.52% | 306,493 | 4.88M |
| 371 | GUTS | Fractyl Health, Inc. | 118.08M | 0.64% | 766,039 | 3.00K |
| 372 | NAUT | Nautilus Biotechnology, Inc. | 115.05M | -3.55% | 522,505 | 190.00K |
| 373 | NTHI | NeOnc Technologies Holdings, Inc. | 114.47M | 0.99% | 99,899 | 39.99K |
| 374 | COYA | Coya Therapeutics, Inc. | 114.00M | -0.21% | 77,621 | 8.02M |
| 375 | SEER | Seer, Inc. | 111.30M | -0.50% | 102,781 | 14.22M |
| 376 | ONCY | Oncolytics Biotech Inc. | 108.38M | -0.65% | 561,074 | - |
| 377 | YARW | Yarrow Bioscience, Inc. | 106.40M | -4.13% | 37,456 | - |
| 378 | PLYX | Polaryx Therapeutics, Inc. | 105.18M | 0.96% | 67,069 | - |
| 379 | PYPD | PolyPid Ltd. | 104.00M | 0.20% | 78,018 | - |
| 380 | CGTX | Cognition Therapeutics, Inc. | 100.80M | 0.95% | 270,483 | - |
| 381 | KLRS | Kalaris Therapeutics, Inc. | 97.60M | 0.49% | 104,886 | - |
| 382 | ACET | Adicet Bio, Inc. | 96.99M | 0.67% | 259,835 | - |
| 383 | PTHS | Pelthos Therapeutics Inc. | 95.71M | -6.65% | 83,493 | 43.30M |
| 384 | FBIO | Fortress Biotech, Inc. | 93.38M | -0.36% | 449,279 | 68.47M |
| 385 | ALDX | Aldeyra Therapeutics, Inc. | 92.90M | -1.28% | 277,004 | - |
| 386 | ATRA | Atara Biotherapeutics, Inc. | 92.85M | -1.39% | 26,949 | 6.19M |
| 387 | ACRV | Acrivon Therapeutics, Inc. | 92.13M | 3.37% | 188,243 | - |
| 388 | ICCC | ImmuCell Corporation | 91.00M | - | 3,181 | 30.68M |
| 389 | RLYB | Rallybio Corporation | 89.00M | -0.71% | 5,875 | 646.00K |
| 390 | VRCA | Verrica Pharmaceuticals Inc. | 87.10M | 3.26% | 533,588 | 30.32M |
| 391 | MAIA | MAIA Biotechnology, Inc. | 83.94M | -0.72% | 263,048 | - |
| 392 | GOSS | Gossamer Bio, Inc. | 83.15M | -2.19% | 15,362,572 | 53.29M |
| 393 | TELO | Telomir Pharmaceuticals, Inc. | 81.84M | 1.71% | 130,161 | - |
| 394 | OKYO | OKYO Pharma Limited | 81.34M | - | 57,273 | - |
| 395 | GANX | Gain Therapeutics, Inc. | 80.74M | 2.21% | 415,607 | - |
| 396 | ATHE | Alterity Therapeutics Limited | 79.50M | -4.60% | 22,761 | 4.43M |
| 397 | CING | Cingulate Inc. | 79.11M | 0.74% | 150,601 | - |
| 398 | DWTX | Dogwood Therapeutics, Inc. | 78.86M | -12.78% | 67,209 | - |
| 399 | ELTX | Elicio Therapeutics, Inc. | 78.85M | 0.67% | 131,201 | - |
| 400 | OSTX | OS Therapies Incorporated | 77.49M | 1.82% | 518,058 | - |
| 401 | ANVS | Annovis Bio, Inc. | 77.12M | 1.69% | 292,173 | - |
| 402 | CRDF | Cardiff Oncology, Inc. | 76.71M | 0.20% | 202,183 | 508.00K |
| 403 | NRXS | NeurAxis, Inc. | 75.60M | 1.01% | 82,658 | 5.32M |
| 404 | LONA | LeonaBio, Inc. | 74.34M | 1.02% | 3,463 | - |
| 405 | PLRX | Pliant Therapeutics, Inc. | 71.21M | -0.86% | 112,816 | - |
| 406 | SPRO | Spero Therapeutics, Inc. | 70.46M | -0.82% | 538,076 | 47.00M |
| 407 | XBIT | XBiotech Inc. | 70.12M | -0.43% | 32,782 | - |
| 408 | MNOV | MediciNova, Inc. | 69.89M | -4.05% | 25,412 | 920.48K |
| 409 | CSBR | Champions Oncology, Inc. | 69.75M | 2.03% | 4,374 | 59.43M |
| 410 | IBIO | iBio, Inc. | 69.55M | -2.10% | 374,396 | 300.00K |
| 411 | BSEM | BioStem Technologies, Inc. | 68.72M | 5.19% | 64,483 | 34.59M |
| 412 | ALPS | Alps Group Inc | 68.22M | -2.37% | 114,173 | 3.74M |
| 413 | RNTX | Rein Therapeutics Inc. | 67.53M | -2.15% | 136,465 | - |
| 414 | RNXT | RenovoRx, Inc. | 66.79M | -0.67% | 427,880 | 1.98M |
| 415 | HYFT | MindWalk Holdings Corp. | 66.72M | -0.70% | 48,943 | 11.43M |
| 416 | INMB | INmune Bio Inc. | 66.61M | -1.84% | 323,473 | 50.00K |
| 417 | EXOZ | eXoZymes, Inc. | 66.59M | -4.65% | 1,062 | -700.00 |
| 418 | PMVP | PMV Pharmaceuticals, Inc. | 66.29M | -5.34% | 197,484 | - |
| 419 | BOLD | Boundless Bio, Inc. | 65.06M | -1.89% | 46,384 | - |
| 420 | ELOX | Eloxx Pharmaceuticals, Inc. | 64.58M | -13.65% | 20,431 | - |
| 421 | SER | Serina Therapeutics, Inc. | 64.01M | -4.18% | 28,781 | 130.00K |
| 422 | HRTX | Heron Therapeutics, Inc. | 63.05M | 6.37% | 1,871,583 | 151.18M |
| 423 | EDSA | Edesa Biotech, Inc. | 62.15M | -6.88% | 81,188 | - |
| 424 | CELU | Celularity Inc. | 60.79M | 138.53% | 219,743,485 | 26.55M |
| 425 | IMA | ImageneBio, Inc. | 60.50M | -1.84% | 17,386 | 800.00K |
| 426 | XLO | Xilio Therapeutics, Inc. | 59.29M | -0.44% | 8,971 | 64.09M |
| 427 | INKT | MiNK Therapeutics, Inc. | 58.19M | -0.93% | 4,698 | - |
| 428 | APLM | Apollomics, Inc. | 57.76M | 0.38% | 1,611 | 8.84M |
| 429 | HYPD | Hyperion DeFi, Inc. | 56.25M | 6.78% | 1,445,864 | 1.40M |
| 430 | NTRB | Nutriband Inc. | 56.16M | 2.67% | 12,955 | 1.80M |
| 431 | ATYR | aTyr Pharma, Inc. | 54.40M | 0.65% | 294,256 | 190.00K |
| 432 | TIL | Instil Bio, Inc. | 53.31M | 0.38% | 8,285 | - |
| 433 | IMMP | Immutep Limited | 53.00M | 0.21% | 128,858 | 5.28M |
| 434 | TCRX | TScan Therapeutics, Inc. | 50.85M | -3.50% | 287,803 | 7.11M |
| 435 | MCRB | Seres Therapeutics, Inc. | 49.21M | 3.99% | 22,833 | 1.88M |
| 436 | IBO | Impact BioMedical Inc. | 47.55M | 0.20% | 51,308 | 35.00K |
| 437 | HOWL | Werewolf Therapeutics, Inc. | 47.18M | -1.82% | 2,203,517 | 21.00M |
| 438 | VERU | Veru Inc. | 46.72M | -2.14% | 122,540 | 16.89M |
| 439 | MGX | Metagenomi Therapeutics, Inc. | 45.71M | -0.82% | 72,612 | 13.56M |
| 440 | GRCE | Grace Therapeutics, Inc. | 45.44M | 0.47% | 82,252 | - |
| 441 | FLNA | Filana Therapeutics, Inc. | 44.59M | -0.15% | 110,327 | - |
| 442 | ALGS | Aligos Therapeutics, Inc. | 44.15M | -5.86% | 80,260 | 31.52M |
| 443 | KPTI | Karyopharm Therapeutics Inc. | 44.00M | -1.02% | 1,105,281 | 146.62M |
| 444 | TVGN | Tevogen Inc. | 43.95M | 0.75% | 3,462 | - |
| 445 | MREO | Mereo BioPharma Group plc | 43.44M | -2.16% | 1,406,458 | 500.00K |
| 446 | ACTU | Actuate Therapeutics, Inc. | 40.58M | -5.06% | 366,075 | - |
| 447 | CRVO | CervoMed Inc. | 39.91M | -0.38% | 108,682 | 331.30K |
| 448 | RNAZ | TransCode Therapeutics, Inc. | 38.60M | -2.56% | 27,445 | - |
| 449 | CNTX | Context Therapeutics Inc. | 38.23M | -1.79% | 1,131,856 | - |
| 450 | VRXA | Veraxa Biotech AG | 36.31M | -12.20% | 488,517 | - |
| 451 | BCTX | BriaCell Therapeutics Corp. | 35.21M | -7.94% | 393,827 | - |
| 452 | IGC | IGC Pharma, Inc. | 34.52M | 8.51% | 3,522,469 | 1.11M |
| 453 | LITS | Lite Strategy, Inc. | 34.03M | 0.69% | 190,122 | - |
| 454 | QNCX | Quince Therapeutics, Inc. | 33.05M | 3.80% | 16,489 | - |
| 455 | KYNB | Kyntra Bio, Inc. | 32.39M | -1.30% | 5,867 | 4.62M |
| 456 | ATNM | Actinium Pharmaceuticals, Inc. | 31.44M | -0.99% | 92,866 | 35.09M |
| 457 | ESLA | Estrella Immunopharma, Inc. | 31.40M | -1.11% | 41,817 | - |
| 458 | RADX | Radiopharm Theranostics Limited | 31.20M | -2.59% | 106,310 | 10.86M |
| 459 | BRNS | Barinthus Biotherapeutics plc | 29.87M | 3.51% | 78,790 | 14.97M |
| 460 | NNVC | NanoViricides, Inc. | 29.16M | - | 222,397 | - |
| 461 | GRDX | GridAI Technologies Corp. | 28.40M | -0.74% | 135,832 | - |
| 462 | CVM | CEL-SCI Corporation | 28.14M | -0.62% | 160,974 | - |
| 463 | NXTC | NextCure, Inc. | 27.62M | 3.52% | 73,251 | - |
| 464 | LTRN | Lantern Pharma Inc. | 27.61M | -0.92% | 139,419 | - |
| 465 | ATOS | Atossa Therapeutics, Inc. | 26.35M | -0.38% | 23,100 | - |
| 466 | BYSI | BeyondSpring Inc. | 26.32M | -7.22% | 289,476 | 1.88M |
| 467 | EVAX | Evaxion A/S | 26.27M | -2.78% | 73,835 | 7.49M |
| 468 | ENLV | Enlivex Ltd. | 25.79M | -2.64% | 517,441 | - |
| 469 | QNTM | Quantum BioPharma Ltd. | 25.04M | 1.95% | 58,326 | - |
| 470 | MRKR | Marker Therapeutics, Inc. | 24.34M | 0.69% | 24,506 | 3.55M |
| 471 | TVRD | Tvardi Therapeutics, Inc. | 24.01M | 1.12% | 70,944 | - |
| 472 | CLRB | Cellectar Biosciences, Inc. | 24.01M | - | 10,299 | - |
| 473 | PLRZ | Polyrizon Ltd. | 23.96M | 9.78% | 23,976 | - |
| 474 | CNSY | Cerenome, Inc. | 23.53M | 2.65% | 69,039 | 4.20M |
| 475 | GNTA | Genenta Science S.p.A. | 23.37M | -12.33% | 84,149 | - |
| 476 | DYAI | Dyadic International, Inc. | 23.29M | -3.18% | 178,852 | 3.80M |
| 477 | JSPR | Jasper Therapeutics, Inc. | 23.27M | -2.62% | 254,173 | - |
| 478 | NIKI | Niki BioSolutions, Inc. | 22.16M | -3.89% | 14,817 | - |
| 479 | COCP | Cocrystal Pharma, Inc. | 21.96M | 1.79% | 44,930 | 330.00K |
| 480 | ALLR | Allarity Therapeutics, Inc. | 21.96M | 2.99% | 49,810 | 345.00K |
| 481 | LGVN | Longeveron Inc. | 21.68M | -3.31% | 130,177 | 1.19M |
| 482 | ABVC | ABVC BioPharma, Inc. | 20.63M | 11.91% | 125,853 | 797.92K |
| 483 | NEUP | Neuphoria Therapeutics Inc. | 20.38M | -2.33% | 50,111 | -13.27K |
| 484 | NCEL | NewcelX Ltd. | 19.75M | 1.18% | 19,827 | - |
| 485 | CMMB | Chemomab Therapeutics Ltd. | 19.71M | 5.02% | 379,565 | - |
| 486 | PTN | Palatin Technologies, Inc. | 19.55M | 0.19% | 62,188 | 12.88M |
| 487 | LEXX | Lexaria Bioscience Corp. | 19.30M | 5.80% | 505,546 | 194.00K |
| 488 | KTTA | Pasithea Therapeutics Corp. | 18.53M | -2.72% | 66,911 | - |
| 489 | LPCN | Lipocine Inc. | 18.38M | 3.72% | 41,462 | 1.57M |
| 490 | CYCN | Cyclerion Therapeutics, Inc. | 18.38M | -3.86% | 97,075 | 1.90M |
| 491 | BCDA | BioCardia, Inc. | 17.71M | -1.68% | 211,550 | 3.00K |
| 492 | AKTX | Akari Therapeutics, Plc | 17.54M | -0.99% | 53,809 | - |
| 493 | CTXR | Citius Pharmaceuticals, Inc. | 17.27M | 8.99% | 824,781 | 7.11M |
| 494 | TPST | Tempest Therapeutics, Inc. | 17.26M | - | 69,440 | - |
| 495 | BIVI | BioVie Inc. | 16.52M | 3.79% | 712,246 | - |
| 496 | PLUR | Pluri Inc. | 16.51M | 3.38% | 100,119 | 1.08M |
| 497 | PBM | Psyence Biomedical Ltd. | 16.44M | -0.23% | 20,178 | - |
| 498 | LSTA | Lisata Therapeutics, Inc. | 16.40M | 0.55% | 86,665 | 100.00K |
| 499 | NRSN | NeuroSense Therapeutics Ltd. | 16.23M | 7.31% | 58,932 | - |
| 500 | CALC | CalciMedica, Inc. | 16.05M | -20.00% | 1,474,140 | - |